A Phase 3 Study to Assess the Efficacy and Safety of PK101 in Patients With Knee Osteoarthritis

NCT04858659 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
354
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PMG Pharm Co., Ltd